Natera Inc (NASDAQ: NTRA) has experienced a rise in its stock price by 5.57 compared to its previous closing price of 132.63. However, the company has seen a fall of -1.64% in its stock price over the last five trading days. businesswire.com reported 2025-03-10 that AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the HEROES clinical trial. HEROES is a multi-center, phase II trial that explores the discontinuation or de-escalation of anti-HER2 targeted therapy among patients with metastatic HER2+ breast cancer. The trial is supported by funding from the French Ministry of Health through the Hospital Clinical Research Program (PHRC) and.
Is It Worth Investing in Natera Inc (NASDAQ: NTRA) Right Now?
The stock has a 36-month beta value of 1.83. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 7 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NTRA is 127.76M, and at present, short sellers hold a 1.95% of that float. On March 12, 2025, the average trading volume of NTRA was 1.59M shares.
NTRA’s Market Performance
The stock of Natera Inc (NTRA) has seen a -1.64% decrease in the past week, with a -18.98% drop in the past month, and a -17.16% fall in the past quarter. The volatility ratio for the week is 7.00%, and the volatility levels for the past 30 days are at 6.11% for NTRA. The simple moving average for the past 20 days is -10.63% for NTRA’s stock, with a 3.39% simple moving average for the past 200 days.
Analysts’ Opinion of NTRA
Many brokerage firms have already submitted their reports for NTRA stocks, with Barclays repeating the rating for NTRA by listing it as a “Overweight.” The predicted price for NTRA in the upcoming period, according to Barclays is $200 based on the research report published on January 23, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see NTRA reach a price target of $142. The rating they have provided for NTRA stocks is “Buy” according to the report published on June 03rd, 2024.
Craig Hallum gave a rating of “Buy” to NTRA, setting the target price at $117 in the report published on April 08th of the previous year.
NTRA Trading at -14.69% from the 50-Day Moving Average
After a stumble in the market that brought NTRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.49% of loss for the given period.
Volatility was left at 6.11%, however, over the last 30 days, the volatility rate increased by 7.00%, as shares sank -18.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.78% lower at present.
During the last 5 trading sessions, NTRA fell by -1.64%, which changed the moving average for the period of 200-days by +29.34% in comparison to the 20-day moving average, which settled at $156.68. In addition, Natera Inc saw -11.55% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NTRA starting from Moshkevich Solomon, who sale 6,000 shares at the price of $143.29 back on Mar 05 ’25. After this action, Moshkevich Solomon now owns 143,768 shares of Natera Inc, valued at $859,734 using the latest closing price.
Chapman Steven Leonard, the CEO AND PRESIDENT of Natera Inc, sale 87,272 shares at $143.40 during a trade that took place back on Mar 05 ’25, which means that Chapman Steven Leonard is holding 203,354 shares at $12,515,006 based on the most recent closing price.
Stock Fundamentals for NTRA
Current profitability levels for the company are sitting at:
- -0.13 for the present operating margin
- 0.6 for the gross margin
The net margin for Natera Inc stands at -0.11. The total capital return value is set at -0.17. Equity return is now at value -19.42, with -12.12 for asset returns.
Based on Natera Inc (NTRA), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at 0.73. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is -20.8.
Currently, EBITDA for the company is -148.08 million with net debt to EBITDA at 5.25. When we switch over and look at the enterprise to sales, we see a ratio of 10.71. The receivables turnover for the company is 5.4for trailing twelve months and the total asset turnover is 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.00.
Conclusion
To sum up, Natera Inc (NTRA) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
